Nuvectis Pharma (NVCT) stock

Worth $725MShares as of Oct 30

$21.08

+0.29%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score NVCT. It is too thinly traded for a fair Quality Score.

Healthcare · Biotech

NextEnd of 2026“We plan to submit a U.S. IND for NXP100 by year-end.”Filing with regulators · SEC filing · Nov 4

Cash$141M, about 14 quarters (3.5 years) at the last year's spendingOn Sep 30 · the company says “into 2H 2029”

Follow NVCT's trial news. Pro members can get an alert when Nuvectis Pharma files news, and see its trials, share raises, and its CEO's filings.

Get an alert when NVCT files news on its trialsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$141M, about 14 quarters (3.5 years) at the last year's spendingOn Sep 30 · the company says “into 2H 2029”

What's next for NVCT, and how long its cash lasts

Next step the company has named

End of 2026“We plan to submit a U.S. IND for NXP100 by year-end.”Filing with regulators · SEC filing · Nov 4

What it means: a filing asks regulators to approve a drug for sale. Once it is complete and accepted, the FDA sets a decision date, and we show it here.

Lead program: NXP100
Another trial: NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung CancerPhase 1 · Recruiting · 18 people · main data estimated Dec 2026 · NCT07315113

2 more trials, 23 filings, for Pro members.

Cash runway Sep 30 balance sheet

About 14 quarters

$141M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money. The company's estimate is “into 2H 2029” (8-K, Nov 4).

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (S-3, filed Aug 21, 2026)
At-the-market share sales program (S-3, filed Aug 21, 2026)

For Pro members: 3 raises and their amounts, and the share count against a year ago.

Insiders

CEO Ron Bentsur bought 12,500 shares on Jun 30.

From Form 4: open-market buys and sales only.

Get an alert when Ron Bentsur buys or sells

For Pro members: every trade, and Ron Bentsur’s 8 filings and quotes.

Get an alert when NVCT files news on its trialsA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

NVCT's latest filings

Quarterly report10-Q, filed Nov 4
Nuvectis Pharma Reports Third Quarter 2026 Financial Results and Business Highlights8-K, filed Nov 4
Shelf registration, to sell securities laterS-3, filed Aug 21

18 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why NVCT isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. NVCT trades about 195,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.